Nouveaux traitements dans l’insuffisance cardiaque systolique : quelle place pour le vericiguat et l’omecamtiv mecarbil ?
- 9 February 2021
- journal article
- other
- Published by Elsevier BV in Archives des Maladies du Coeur et des Vaisseaux - Pratique
- Vol. 2021 (296), 6-8
- https://doi.org/10.1016/j.amcp.2021.01.001
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit:
- Vericiguat in Patients with Heart Failure and Reduced Ejection FractionThe New England Journal of Medicine, 2020